AKTS · Company research
Aktis Oncology, Inc. Common stock (AKTS): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 17.86 | $944,881,638.34 | 573251638.34 | — | — | — | 292.8049700464828014 | 1.8669565356406143 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.